References
- Antinori A, Cingolani A, De Luca A, Gaidano GL, Ammassari A, Larocca LM, Ortona L (1999). Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Ann Neurol 45: 259–261.
- Arribas JR, Clifford DB, Fichtenbaum CJ, Roberts RL, Powderly WG, Storch GA (1995). Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. I Clin Microbiol 33: 1580–1583.
- Cingolani A, Gastaldi R, Fassone L, Piercorti F, Giancola ML, Martini M, De Luca A, Ammassari A, Mazzone C, Pescarmor a E, Gaidano GL, Larocca LM, Antinori A (2000). Epstein-Barr infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. I Clin Oncol 18: 3325–3330.
- Cinque P, Brytting M, Vago L, Castagna A, Paravicini C, Zanchetta N, D'Arminio Monforte A, Wahren B, Lazzarin A, Linde (1993). Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related pri-mary lymphoma of the central nervous system. Lancet 342: 398–401.
- Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fornara C, Racca S, Castagna A, D'Arminio Monforte A, Wahren B, Lazzarin A, Linde A (1996). Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951–958.
- De Luca A, Antinori A, Cingolani A, Larocca LM, Linzalone A, Ammassari A, Scerrati M, Roselli R, Tamburini E, Ortona L (1995). Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 90: 844–849.
- Enbom M, Strand A, Falk KI, Linde A (2001). Detection of EBV, but not HHV-8, DNA in cervical secretions from Swedish women by real-time PCR. Sex Transm Dis 28: 300–306.
- Ernberg I, Altiok E (1989). The role of Epstein-Barr virus in lymphomas of HIV-carriers. APMIS Suppl 8: 58–61.
- Fong IW, Ho J, Lo B, Fong MW (2000). Value of chronic administration of acyclovir and similar agents for pro-tecting against AIDS-related lymphoma: Case control and historical cohort studies. Clin Infect Dis 30: 757–761.
- Grulich AE (1999). AIDS-associated non-Hodgkin's lym-phoma in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 21: S27–S30.
- Kenagy DN, Schlesinger Y, Weck K, Ritter JN, Gaudreault-Keener MM, Storch GA (1995). Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post-transplant lymphoproliferative disease. Transplant 60: 547.
- Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T (1999). Quantita-tive analysis of Epstein-Barr virus load by using a real-time PCR assay. I Clin Microbiol 37: 132–136.
- Laroche C, Drouet EB, Brousset P, Pain C, Boibieux A, Biron F, Icart J, Denoyel GA, Niveleau A (1995). Measurement by polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas. J Med Virol 46: 66–74.
- Levine AM (1992). Acquired immunodeficiency syndrome-related lymphoma. Blood 80: 8–20.
- Limaye AP, Huang ML, Atienza EE, Ferrenberg JM, Corey L (1999). Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative dis-orders. I Clin Microbiol 37: 1113–1116.
- Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emmanuel DJ (1998). Semi-quantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91: 3654–3661.
- MacMahon EM, Glass JD, Hayward SD, Mann RB, Scott-Becker P, Charache P, McArthur JC, Ambinder RF (1991). Epstein-Barr virus in AIDS-related primary central ner-vous system lymphoma. Lancet 338: 969–974.
- Niesters HGM, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus ADME (2000). Development of a real-time quantitative assay for detection of Epstein-Barr virus. I Clin Microbiol 38: 712–715.
- Rabkin CS, Marcia AT, Huang J, Von Roenn JH (1999). Kaposi's sarcoma and non-Hodgkin's lymphoma inci-dence trends in AIDS clinical trial group study partici-pants. I Acquir Immune Defic Syndr Hum Retrovirol 21: S31–S33.
- Raez L, Cabral L, Cai JP, Landy H, Sfakianakis G, Byrne GE, Hurley J, Sarpella E, Jahaweera D, Harrington WJ, Jr (1999). Treatment of AIDS-related primary central ner-vous system lymphoma with zidovudine, ganciclovir and interleukin 2. AIDS Res Hum Retroviruses 15: 713–719.
- Rickinson AB, Kieff E (1996). Epstein-Barr virus. In: Fields virology, Fields BN (ed.). Philadelphia, PA: Lippincott-Raven, pp. 2397–2446.
- Schmidt W, Anagnostopoulos I, Scherubl H (2000). Viro-static therapy for advanced lymphoproliferation asso-ciated with the Epstein-Barr virus in an HIV-infected patients (letter). N Engl J. Med 342: 440–441.
- Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM (1993). Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients in-fected with the human immunodeficiency virus. Blood 81: 2102–2109.
- Stevens SJC, Vervoot MBHJ, van den Brule AJC, Meenhorst PL, Meijer JLM, Middelhorp JM (1999). Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR. J Clin Microbiol 37: 2852–2857.